Tag: #eacrVirtualEvents

Vinodh Kumar

Virtual Defence is the Best Attack 2021: A Participant’s View

In February 2021, we held a 2-day virtual conference on the the topic of Immuno-Oncology. If you woud like to know more about the...

“They enlightened and enriched us” – EACR Defence is the Best...

Mid-February saw the first EACR virtual conference of the year - the third edition on the topic of immuno-oncology, where participants learned about the...
Saber Imani

Virtual Liquid Biopsies 2020: A Participant’s View

In November 2020, we held a 2-day Virtual Conference on the the topic of Liquid Biopsies, replacing the in-person event that would have been...

“This conference is a class above the current alternatives” – EACR...

In November, the EACR held our second conference on Liquid Biopsies, this time in a virtual format. Over two afternoons there were 7 invited...

VIDEO: Nitzan Rosenfeld gives the Pezcoller Foundation – EACR Cancer Researcher...

At the EACR Virtual Congress in June Dr. Nitzan Rosenfeld gave his keynote lecture as the winner of the 2020 Pezcoller Foundation – EACR...
Pier Guiseppe Pelicci

EACR Virtual Congress 2020: “Highly enriching and a great experience”

The COVID-19 crisis meant a lot of people had to change their plans for 2020 very quickly. We weren't able to hold our Congress...

VIDEO: Why are papers rejected? How can you become a peer-reviewer?...

At the Virtual EACR Congress in June, we gathered senior editors from top cancer research journals for an insightful discussion about scientific publication. Professors Alberto...

Who are we?

The Cancer Researcher is an online magazine for the cancer research community from the European Association for Cancer Research.

Advertisement
Advertisement
Advertisement
Advertisement

Popular articles

EACR top 10 cancer research publications

The EACR’s Top 10 Cancer Research Publications: April 2019

The EACR's Top 10 Cancer Research Publications is a regular summary of the most interesting and impactful recent papers in cancer research. It is...